COVID-19: 3-drug combo treatment may be successful
A phase II clinical trial has found that a combination of three drugs — interferon beta-1b, lopinavir-ritonavir, and ribavirin — plus standard care is successful in treating mild-to-moderate cases of COVID-19. MedicalNewsToday
No comments:
Post a Comment